Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Oncology Drugs Market Share, Growth, Trends, Analysis Forecast: By Drug Class: Cytotoxic drugs, Hormonal drugs, Targeted drugs, Others; By Therapy: Immunotherapy, Chemotherapy, Targeted Therapy; By Indication: Stomach Cancer, Others; By Dosage Form; By Distribution Channels; Regional Analysis; Competitive Landscape; 2023-2028

Global Oncology Drugs Market Outlook

The global oncology drugs market size reached a value of more than USD 156.73 billion in 2022. The global market is expected to grow at a CAGR of 7.30% during the forecast period of 2023-2028 to attain a value of USD 239.19 billion by 2028. The growth of the market can be attributed to the rising prevalence of cancer across the globe.

 

Global Oncology Drugs Market Trends

Oncology is a branch of science that focuses on the study of tumours and cancers. The studies are conducted to develop treatment, diagnosis, and prevention methods for cancer. The treatment methods include medical oncology, radiation oncology, and surgical oncology, among other drugs. Oncology drugs are specific medicines that are manufactured and utilized to target tumour cells.

 

  • The deteriorating lifestyle and poor diets of people due to the hectic lifestyles are some of the largest contributors to the rise in cancer cases. The rising prevalence of cancer cases around the world is one of the primary factors propelling the oncology market development as patients continue to seek treatment.
  • Key companies and government agencies are making rapid development in the treatment of cancer. Increased investments are being made in the research and development of immunotherapy as a cancer treatment method and improving its efficiency, which can significantly enhance the market value.
  • Key market players and healthcare institutes are increasing their efforts in introducing innovative cancer treatments and simultaneously raising awareness for the available treatments in the market. With the rising awareness among people, patients are increasingly opting for treatment, which in turn, will increase the demand for certain treatment methods.

 

Global Oncology Drugs Market Analysis

Based on drug class, the market can be segmented into cytotoxic drugs, hormonal drugs, and targeted drugs, among others. Based on therapy, the market can be bifurcated into immunotherapy, chemotherapy, and targeted therapy. Based on indication, the market can be divided into stomach cancer, colorectal cancer, prostate cancer, lung cancer, breast cancer, skin cancer, and bladder cancer, among others. 

 

Based on dosage form, the market can be segmented into solids, liquids, and injectables. Based on distribution channels, the market bifurcations include retail pharmacies, online pharmacies, and hospital pharmacies, among others. The regional markets can be divided into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. 

 

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following oncology drugs market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments and expansion plans. 

 

  • Abbvie Inc.
  • Amgen, Inc.
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Others

 

Drug Classes for Oncology Available in the Market

The market, based on drug class, can be categorised into cytotoxic drugs, targeted drugs, and hormonal drugs, among others. The targeted drug segment is expected to hold a dominant position in the market owing to the various advantages it provides during treatment procedures.

 

The treatment is directly focused on the disease and it allows to minimise side-effects that affect the normal cells in the surroundings. Due to such characteristics, the market demand for targeted drugs is constantly rising.

 

Different Therapies in the Oncology Drugs Market

Based on therapy, the market can be bifurcated into immunotherapy, chemotherapy, and targeted therapy. Among these segments, the targeted therapy segment will hold a significant position in the market owing to the rising awareness about targeted therapies in developing regions.

 

With the increasing prevalence of cancer cases, the market for targeted therapies is expected to expand further owing to its ability to specifically target the cancerous cells and treat certain types of metastatic cancer.

 

Competitive Landscape

Abbvie Inc. is a biopharmaceutical manufacturing company, founded in 2013 after separating from Abbott. The company works in the healthcare industry with an interest to develop innovative medicines and products that are capable of solving chronic diseases and enhancing lives.

 

The company is headquartered in Illinois, United States, and operates in different therapeutic focus areas, such as immunology, oncology, neuroscience, virology, eye care, women’s health, and gastroenterology. 

 

Amgen, Inc. is a multinational biopharmaceutical company, pioneering the science of using living cells to make biological medicines. The company was founded in 1980 and specialises in biologics, human therapeutics, and the development of novel products for the treatment of complex diseases. The company utilises its expertise to develop innovations that can enable treatment solutions to improve peoples’ life. They have expanded their presence in over 100 countries and provide their products through various brands, including Aimovig, Avsola, Epogen, Evenity, and Corlanor, among others.

 

AstraZeneca plc. is a British-Swedish multinational pharmaceutical and biotechnology company, founded in 1999. The company is headquartered in Cambridge, United Kingdom, and is actively operating to introduce innovative and effective medicines. Their operations span more than 100 countries with a focus on manufacturing medicines in different fields, including oncology, cardiovascular and metabolic disease (CVMD), and respiratory. The company is also selectively active in areas of autoimmunity, neuroscience, and infection.

 

Other market players include F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Merck & Co., Inc., and Novartis AG, among others.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug Class
  • Therapy
  • Indication
  • Dosage Form
  • Distribution Channels
  • Region
Breakup by Drug Class
  • Cytotoxic drugs
  • Hormonal drugs
  • Targeted drugs
  • Others
Breakup by Therapy
  • Immunotherapy
  • Chemotherapy
  • Targeted Therapy
Breakup by Indication
  • Stomach Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Skin Cancer
  • Bladder Cancer
  • Others
Breakup by Dosage Form
  • Solids
  • Liquids
  • Injectable
Breakup by Distribution Channels
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Abbvie Inc.
  • Amgen, Inc.
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Oncology Drugs Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Oncology Drugs Historical Market (2018-2022) 
    8.3    Global Oncology Drugs Market Forecast (2023-2028)
    8.4    Global Oncology Drugs Market by Drug Class
        8.4.1    Cytotoxic drugs
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Hormonal drugs
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
        8.4.3    Targeted drugs
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
        8.4.4    Others
    8.5    Global Oncology Drugs Market by Therapy
        8.5.1    Immunotherapy
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Chemotherapy
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Targeted Therapy
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
    8.6    Global Oncology Drugs Market by Indication
        8.6.1    Stomach Cancer
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Colorectal Cancer
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Prostate Cancer
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2022)
            8.6.3.3    Forecast Trend (2023-2028)
        8.6.4    Lung Cancer
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2018-2022)
            8.6.4.3    Forecast Trend (2023-2028)    
        8.6.5    Breast Cancer
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2018-2022)
            8.6.5.3    Forecast Trend (2023-2028)    
        8.6.6    Skin Cancer
            8.6.6.1    Market Share
            8.6.6.2    Historical Trend (2018-2022)
            8.6.6.3    Forecast Trend (2023-2028)    
        8.6.7    Bladder Cancer
            8.6.7.1    Market Share
            8.6.7.2    Historical Trend (2018-2022)
            8.6.7.3    Forecast Trend (2023-2028)    
        8.6.8    Others    
    8.7    Global Oncology Drugs Market by Dosage Form
        8.7.1    Solids
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2018-2022)
            8.7.1.3    Forecast Trend (2023-2028)
        8.7.2    Liquids
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2018-2022)
            8.7.2.3    Forecast Trend (2023-2028)
        8.7.3    Injectable 
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2018-2022)
            8.7.3.3    Forecast Trend (2023-2028)
    8.8    Global Oncology Drugs Market by Distribution Channels
        8.8.1    Retail Pharmacies
            8.8.1.1    Market Share
            8.8.1.2    Historical Trend (2018-2022)
            8.8.1.3    Forecast Trend (2023-2028)
        8.8.2    Online Pharmacies
            8.8.2.1    Market Share
            8.8.2.2    Historical Trend (2018-2022)
            8.8.2.3    Forecast Trend (2023-2028)
        8.8.3    Hospital Pharmacies 
            8.8.3.1    Market Share
            8.8.3.2    Historical Trend (2018-2022)
            8.8.3.3    Forecast Trend (2023-2028)
        8.8.4    Others
    8.9    Global Oncology Drugs Market by Region
        8.9.1    North America
            8.9.1.1    Market Share
            8.9.1.2    Historical Trend (2018-2022) 
            8.9.1.3    Forecast Trend (2023-2028)
        8.9.2    Europe
            8.9.2.1    Market Share
            8.9.2.2    Historical Trend (2018-2022) 
            8.9.2.3    Forecast Trend (2023-2028)
        8.9.3    Asia Pacific
            8.9.3.1    Market Share
            8.9.3.2    Historical Trend (2018-2022) 
            8.9.3.3    Forecast Trend (2023-2028)
        8.9.4    Latin America
            8.9.4.1    Market Share
            8.9.4.2    Historical Trend (2018-2022) 
            8.9.4.3    Forecast Trend (2023-2028)
        8.9.5    Middle East and Africa
            8.9.5.1    Market Share
            8.9.5.2    Historical Trend (2018-2022) 
            8.9.5.3    Forecast Trend (2023-2028)
9    North America Oncology Drugs Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022) 
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022) 
        9.2.3    Forecast Trend (2023-2028)
10    Europe Oncology Drugs Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022) 
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022) 
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022) 
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022) 
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Oncology Drugs Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022) 
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022) 
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022) 
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022) 
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022) 
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin America Oncology Drugs Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022) 
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022) 
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022) 
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and Africa Oncology Drugs Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022) 
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022) 
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022) 
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022) 
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Abbvie Inc.
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Amgen, Inc.
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    AstraZeneca PLC
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    F. Hoffmann-La Roche Ltd
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Johnson & Johnson Services, Inc.
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Merck & Co., Inc.
            15.2.6.1    Company Overview
            15.2.6.2    Product Portfolio
            15.2.6.3    Demographic Reach and Achievements
            15.2.6.4    Certifications
        15.2.7    Novartis AG
            15.2.7.1    Company Overview
            15.2.7.2    Product Portfolio
            15.2.7.3    Demographic Reach and Achievements
            15.2.7.4    Certifications
        15.2.8    Others
16    Key Trends and Developments in the Market

 

Additional Customisations Available

1    Manufacturing Process
    1.1    Overview
    1.2    Detailed Process Flow
    1.3    Operation Involved
2    Project Requirement and Cost Analysis
    2.1    Land, Location and Site Development
    2.2    Construction
    2.3    Plant Machinery
    2.4    Cost of Raw Material
    2.5    Packaging
    2.6    Transportation
    2.7    Utilities
    2.8    Manpower
    2.9    Other Capital Investment

 

List of Key Figures and Tables

1.    Global Oncology Drugs Market: Key Industry Highlights, 2018 and 2028
2.    Global Oncology Drugs Historical Market: Breakup by Drug Class (USD Billion), 2018-2022
3.    Global Oncology Drugs Market Forecast: Breakup by Drug Class (USD Billion), 2023-2028
4.    Global Oncology Drugs Historical Market: Breakup by Therapy (USD Billion), 2018-2022
5.    Global Oncology Drugs Market Forecast: Breakup by Therapy (USD Billion), 2023-2028
6.    Global Oncology Drugs Historical Market: Breakup by Indication (USD Billion), 2018-2022
7.    Global Oncology Drugs Market Forecast: Breakup by Indication (USD Billion), 2023-2028
8.    Global Oncology Drugs Historical Market: Breakup by Dosage Form (USD Billion), 2018-2022
9.    Global Oncology Drugs Market Forecast: Breakup by Dosage Form (USD Billion), 2023-2028
10.    Global Oncology Drugs Historical Market: Breakup Distribution Channel (USD Billion), 2018-2022
11.    Global Oncology Drugs Market Forecast: Breakup by Distribution Channel (USD Billion), 2023-2028
12.    Global Oncology Drugs Historical Market: Breakup by Region (USD Billion), 2018-2022
13.    Global Oncology Drugs Market Forecast: Breakup by Region (USD Billion), 2023-2028
14.    North America Oncology Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
15.    North America Oncology Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
16.    Europe Oncology Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
17.    Europe Oncology Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
18.    Asia Pacific Oncology Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
19.    Asia Pacific Oncology Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
20.    Latin America Oncology Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
21.    Latin America Oncology Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
22.    Middle East and Africa Oncology Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
23.    Middle East and Africa Oncology Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
24.    Global Oncology Drugs Market Structure

Key Questions Answered in the Report

The global market for oncology drugs attained a value of USD 156.73 billion in 2022.

The market is likely to grow at a CAGR of 7.30% during the forecast period of 2023-2028.

The market is expected to reach a value of USD 239.19 billion by 2028.

The poor food habits and lifestyle of people has propelled the rising number of cancer cases around the world. Along with that, the increasing research and development activities conducted for the launching of novel treatment products are the major drivers for market development.

The rising awareness among people about the treatment is a key trend which is bolstering the market growth. Moreover, market players and government agencies increasingly investing in the development of cancer treatment solutions are expected to deliver new growth opportunities to the market.

The regional markets include North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

The different classes of drugs include cytotoxic drugs, hormonal drugs, and targeted drugs, among others.

 The oncology drug therapies include immunotherapy, chemotherapy, and targeted therapy.

The different indications in the market for oncology drugs include stomach cancer, colorectal cancer, prostate cancer, lung cancer, breast cancer, skin cancer, and bladder cancer, among others.

Various dosage forms used for oncology drugs include solids, liquids, and injectable.

The market utilizes various distribution channels such as retail pharmacies, online pharmacies, and hospital pharmacies, among others.

The key players in the market include Abbvie Inc., Amgen, Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Merck & Co., Inc., and Novartis AG, among others.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER